Cargando…
Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1
Renal cell carcinoma (RCC) is the second most common human urinary tumor. Eupatilin is the main active ingredient of the traditional Chinese medicine Artemisia asiatica. The effect of Eupatilin on RCC and the underlying mechanism remain unknown. Here, we investigated the anticancer effects and mecha...
Autores principales: | Zhong, Weifeng, Wu, Zhiming, Chen, Nanhui, Zhong, Kaihua, Lin, Yifeng, Jiang, Huiming, Wan, Pei, Lu, Shanming, Yang, Lawei, Liu, Siping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507163/ https://www.ncbi.nlm.nih.gov/pubmed/31179326 http://dx.doi.org/10.1155/2019/5016483 |
Ejemplares similares
-
Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021) -
Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Huiming, et al.
Publicado: (2020) -
BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma
por: Wan, Pei, et al.
Publicado: (2020) -
Eupatilin Ameliorates Collagen Induced Arthritis
por: Kim, Juryun, et al.
Publicado: (2015) -
Eupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in Chondrocytes
por: Jeong, Jeong-Hee, et al.
Publicado: (2015)